The efficacy and cost-effectiveness of a family-based economic empowerment intervention (Suubi + Adherence) on suppression of HIV viral loads among adolescents living with HIV: results from a Cluster Randomized Controlled Trial in southern Uganda.


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
06 2021
Historique:
revised: 24 04 2021
received: 13 10 2020
accepted: 05 05 2021
entrez: 27 6 2021
pubmed: 28 6 2021
medline: 16 10 2021
Statut: ppublish

Résumé

Evidence from low-resource settings indicates that economic insecurity is a major barrier to HIV treatment adherence. Economic empowerment (EE) interventions have the potential to improve adherence outcomes among adolescents living with HIV (ALWHIV) by mitigating the effects of poverty. This study aims to assess the efficacy and cost-effectiveness of a savings-led family-based EE intervention, Suubi + Adherence, aimed at improving antiretroviral therapy (ART) adherence outcomes ALWHIV in Uganda. Adolescents (mean age 12 years at enrolment; 56% female) receiving ART for HIV at 39 health centres were randomized to Suubi + Adherence intervention (n = 358) or bolstered standard of care (BSOC; n = 344). A difference-in-differences analysis was employed to assess the change in the proportion of virally suppressed adolescents (HIV RNA viral load <40 copies/mL) over 24 months. The cost-effectiveness analysis examined how much the intervention cost to virally suppress one additional adolescent relative to BSOC from the healthcare provider perspective. At 24 months, the intervention was associated with an 8.85-percentage point [95% confidence interval (CI) 0.80 to 16.90 percentage points] increase in the proportion of virally suppressed adolescents between the study arms (p = 0.032). Per-participant costs were US$177 and US$263 for the BSOC and intervention groups respectively. The incremental cost of virally suppressing one additional adolescent was estimated at US$970 [95% CI, US$508 to 10,725] over two years. Our results support the integration of family-based EE interventions into adherence-support strategies as part of routine HIV care in low-resource settings to address the underlying economic drivers of poor ART adherence among ALWHIV. Moreover, per-participant costs to achieve viral suppression do not seem prohibitive compared to other community-based adherence interventions targeted at ALWHIV in low-resource settings. Further research on combination interventions at the nexus of economic security and HIV treatment and care is needed to inform the development of feasible and scalable HIV policies and programmes.

Identifiants

pubmed: 34176245
doi: 10.1002/jia2.25752
pmc: PMC8236226
doi:

Banques de données

ClinicalTrials.gov
['NCT01790373']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25752

Subventions

Organisme : NIMH NIH HHS
ID : P30 MH062246
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD074949
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH067127
Pays : United States

Informations de copyright

© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

Contemp Clin Trials Commun. 2019 Oct 20;16:100463
pubmed: 31872152
BMC Infect Dis. 2019 Feb 15;19(1):169
pubmed: 30770728
Pharmacoeconomics. 2013 Dec;31(12):1155-68
pubmed: 24222477
Curr Opin HIV AIDS. 2018 May;13(3):212-219
pubmed: 29570471
Prev Sci. 2016 Jan;17(1):134-43
pubmed: 26228480
Trop Med Int Health. 2017 Apr;22(4):375-387
pubmed: 28102610
Value Health. 2013 Mar-Apr;16(2):231-50
pubmed: 23538175
AIDS Behav. 2018 Nov;22(11):3763-3772
pubmed: 29846836
Cochrane Database Syst Rev. 2014 Nov 20;(11):CD000011
pubmed: 25412402
BMC Infect Dis. 2015 Nov 14;15:520
pubmed: 26573923
Curr Opin Infect Dis. 2012 Feb;25(1):17-25
pubmed: 22156900
AIDS. 2018 Sep 24;32(15):2179-2188
pubmed: 30134294
Lancet Glob Health. 2020 Feb;8(2):e264-e275
pubmed: 31924539
Value Health. 2015 Mar;18(2):161-72
pubmed: 25773551
Lancet Child Adolesc Health. 2017 Nov;1(3):175-183
pubmed: 29104904
JAMA. 2014 Dec 10;312(22):2401-2
pubmed: 25490331
AIDS Care. 2015;27(7):805-16
pubmed: 25702789
AIDS. 2011 Nov 28;25(18):2259-68
pubmed: 21918422
Sex Transm Dis. 2006 Oct;33(10 Suppl):S145-52
pubmed: 17003679
AIDS. 2006 Jan 2;20(1):101-9
pubmed: 16327325
J Acquir Immune Defic Syndr. 2009 May 1;51(1):65-71
pubmed: 19282780
PLoS One. 2020 Feb 10;15(2):e0228370
pubmed: 32040523
JAMA Pediatr. 2017 Jun 1;171(6):573-592
pubmed: 28384795
Expert Opin Pharmacother. 2006 Feb;7(2):135-43
pubmed: 16433579
PLoS Med. 2012;9(7):e1001231
pubmed: 22807656
J Int AIDS Soc. 2021 Jun;24(6):e25752
pubmed: 34176245
J Adolesc Health. 2014 Feb;54(2):121-38
pubmed: 24182940
Glob Public Health. 2017 Aug;12(8):1033-1050
pubmed: 26313708
PLoS One. 2019 Dec 31;14(12):e0226809
pubmed: 31891601
Value Health. 2019 Feb;22(2):194-202
pubmed: 30711064

Auteurs

Yesim Tozan (Y)

School of Global Public Health, New York University, New York, NY, USA.

Ariadna Capasso (A)

School of Global Public Health, New York University, New York, NY, USA.

Sicong Sun (S)

Brown School, Washington University in Saint Louis, Saint Louis, MO, USA.
International Center for Child Health and Development, Brown School, Washington University in St. Louis, St. Louis, MO, USA.

Torsten B Neilands (TB)

Center for AIDS Prevention Studies, School of Medicine, University of California, San Francisco, CA, USA.

Christopher Damulira (C)

International Center for Child Health and Development, Washington University in St. Louis, Uganda Field Office, Masaka, Uganda.

Flavia Namuwonge (F)

International Center for Child Health and Development, Washington University in St. Louis, Uganda Field Office, Masaka, Uganda.

Gertrude Nakigozi (G)

Rakai Health Sciences Program, Kalisizo, Uganda.

Abel Mwebembezi (A)

International Center for Child Health and Development, Washington University in St. Louis, Uganda Field Office, Masaka, Uganda.
Reach the Youth (RTY) Uganda, Kampala, Uganda.

Barbara Mukasa (B)

Mildmay Uganda, Kampala, Uganda.

Ozge Sensoy Bahar (O)

Brown School, Washington University in Saint Louis, Saint Louis, MO, USA.
International Center for Child Health and Development, Brown School, Washington University in St. Louis, St. Louis, MO, USA.

Proscovia Nabunya (P)

Brown School, Washington University in Saint Louis, Saint Louis, MO, USA.
International Center for Child Health and Development, Brown School, Washington University in St. Louis, St. Louis, MO, USA.

Claude A Mellins (CA)

HIV Center for Clinical and Behavioral Studies, Department of Psychiatry, New York State Psychiatric Institute and Columbia University, New York, NY, USA.

Mary M McKay (MM)

Brown School, Washington University in Saint Louis, Saint Louis, MO, USA.

Fred M Ssewamala (FM)

Brown School, Washington University in Saint Louis, Saint Louis, MO, USA.
International Center for Child Health and Development, Brown School, Washington University in St. Louis, St. Louis, MO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH